Cargando…
Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is airway inflammation characterized and low daily physical activity. Most pulmonary rehabilitation (PR) programs are often provided to stable patients, but fewer training programs are specific for hospitalized patients with acute exacerbation...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158083/ https://www.ncbi.nlm.nih.gov/pubmed/32293463 http://dx.doi.org/10.1186/s12931-020-1328-z |
_version_ | 1783522466753150976 |
---|---|
author | Tung, Lan-Fang Shen, Sheng-Yeh Shih, Hui-Hsuan Chen, Yen-Ting Yen, Chia-te Ho, Shu-Chuan |
author_facet | Tung, Lan-Fang Shen, Sheng-Yeh Shih, Hui-Hsuan Chen, Yen-Ting Yen, Chia-te Ho, Shu-Chuan |
author_sort | Tung, Lan-Fang |
collection | PubMed |
description | BACKGROUND: Chronic obstructive pulmonary disease (COPD) is airway inflammation characterized and low daily physical activity. Most pulmonary rehabilitation (PR) programs are often provided to stable patients, but fewer training programs are specific for hospitalized patients with acute exacerbation (AE). Patients with AECOPD experience increased dyspnea sensations and systemic inflammation during exercise training. High-flow nasal therapy (HFNT) reduces the minute volume, lowers the respiratory rate, and decreases the work of breathing. However, it is not clear whether HFNT is efficient during exercise training. In this study, we investigated the effects of HFNT during exercise training in an early PR program among hospitalized patients with severe AECOPD. METHODS: We enrolled COPD patients hospitalized due to AE. They were randomized into two groups according to their status into HFNT PR and non-HFNT PR groups. This study collected basic data, and also assessed a pulmonary function test, 6-min walking test, blood inflammatory biomarkers, and arterial gas analysis at the baseline, and at 4 and 12 weeks of the intervention. Data were analyzed using SPSS statistical software. RESULT: We recruited 44 AECOPD patients who completed the 12-week PR program. The HFNT PR program produced significant improvements in exercise tolerance as assessed by the 6-min walking distance (6MWD), reduced dyspnea sensations in the modified Medical Research Council (mMRC), and decreased systemic inflammation as evidenced by the a lower C-reactive protein (CRP) level. A reduction in the length of hospitalization was achieved with PR in the 1-year follow-up in the two groups. The HFNT PR group showed better trends of reduced air trapping in the delta inspiration capacity (IC) and an increased quality of life according to the COPD assessment test (CAT) than did the non-HFNT PR group. CONCLUSIONS: HFNT during exercise training in early PR increases exercise tolerance and reduces systemic inflammation in hospitalized patients with severe AECOPD. |
format | Online Article Text |
id | pubmed-7158083 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-71580832020-04-21 Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study Tung, Lan-Fang Shen, Sheng-Yeh Shih, Hui-Hsuan Chen, Yen-Ting Yen, Chia-te Ho, Shu-Chuan Respir Res Research BACKGROUND: Chronic obstructive pulmonary disease (COPD) is airway inflammation characterized and low daily physical activity. Most pulmonary rehabilitation (PR) programs are often provided to stable patients, but fewer training programs are specific for hospitalized patients with acute exacerbation (AE). Patients with AECOPD experience increased dyspnea sensations and systemic inflammation during exercise training. High-flow nasal therapy (HFNT) reduces the minute volume, lowers the respiratory rate, and decreases the work of breathing. However, it is not clear whether HFNT is efficient during exercise training. In this study, we investigated the effects of HFNT during exercise training in an early PR program among hospitalized patients with severe AECOPD. METHODS: We enrolled COPD patients hospitalized due to AE. They were randomized into two groups according to their status into HFNT PR and non-HFNT PR groups. This study collected basic data, and also assessed a pulmonary function test, 6-min walking test, blood inflammatory biomarkers, and arterial gas analysis at the baseline, and at 4 and 12 weeks of the intervention. Data were analyzed using SPSS statistical software. RESULT: We recruited 44 AECOPD patients who completed the 12-week PR program. The HFNT PR program produced significant improvements in exercise tolerance as assessed by the 6-min walking distance (6MWD), reduced dyspnea sensations in the modified Medical Research Council (mMRC), and decreased systemic inflammation as evidenced by the a lower C-reactive protein (CRP) level. A reduction in the length of hospitalization was achieved with PR in the 1-year follow-up in the two groups. The HFNT PR group showed better trends of reduced air trapping in the delta inspiration capacity (IC) and an increased quality of life according to the COPD assessment test (CAT) than did the non-HFNT PR group. CONCLUSIONS: HFNT during exercise training in early PR increases exercise tolerance and reduces systemic inflammation in hospitalized patients with severe AECOPD. BioMed Central 2020-04-15 2020 /pmc/articles/PMC7158083/ /pubmed/32293463 http://dx.doi.org/10.1186/s12931-020-1328-z Text en © The Author(s). 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Tung, Lan-Fang Shen, Sheng-Yeh Shih, Hui-Hsuan Chen, Yen-Ting Yen, Chia-te Ho, Shu-Chuan Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study |
title | Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study |
title_full | Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study |
title_fullStr | Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study |
title_full_unstemmed | Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study |
title_short | Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study |
title_sort | effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe aecopd: a randomized controlled study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158083/ https://www.ncbi.nlm.nih.gov/pubmed/32293463 http://dx.doi.org/10.1186/s12931-020-1328-z |
work_keys_str_mv | AT tunglanfang effectofhighflownasaltherapyduringearlypulmonaryrehabilitationinpatientswithsevereaecopdarandomizedcontrolledstudy AT shenshengyeh effectofhighflownasaltherapyduringearlypulmonaryrehabilitationinpatientswithsevereaecopdarandomizedcontrolledstudy AT shihhuihsuan effectofhighflownasaltherapyduringearlypulmonaryrehabilitationinpatientswithsevereaecopdarandomizedcontrolledstudy AT chenyenting effectofhighflownasaltherapyduringearlypulmonaryrehabilitationinpatientswithsevereaecopdarandomizedcontrolledstudy AT yenchiate effectofhighflownasaltherapyduringearlypulmonaryrehabilitationinpatientswithsevereaecopdarandomizedcontrolledstudy AT hoshuchuan effectofhighflownasaltherapyduringearlypulmonaryrehabilitationinpatientswithsevereaecopdarandomizedcontrolledstudy |